Reply to B. Rini et al and S. Buti et al.
Publication
, Journal Article
Choueiri, TK; Halabi, S; Morris, MJ; George, D
Published in: J Clin Oncol
June 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2017
Volume
35
Issue
16
Start / End Page
1859 / 1860
Location
United States
Related Subject Headings
- Sunitinib
- Pyridines
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- Anilides
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Choueiri, T. K., Halabi, S., Morris, M. J., & George, D. (2017). Reply to B. Rini et al and S. Buti et al. J Clin Oncol, 35(16), 1859–1860. https://doi.org/10.1200/JCO.2017.72.2629
Choueiri, Toni K., Susan Halabi, Michael J. Morris, and Daniel George. “Reply to B. Rini et al and S. Buti et al.” J Clin Oncol 35, no. 16 (June 1, 2017): 1859–60. https://doi.org/10.1200/JCO.2017.72.2629.
Choueiri TK, Halabi S, Morris MJ, George D. Reply to B. Rini et al and S. Buti et al. J Clin Oncol. 2017 Jun 1;35(16):1859–60.
Choueiri, Toni K., et al. “Reply to B. Rini et al and S. Buti et al.” J Clin Oncol, vol. 35, no. 16, June 2017, pp. 1859–60. Pubmed, doi:10.1200/JCO.2017.72.2629.
Choueiri TK, Halabi S, Morris MJ, George D. Reply to B. Rini et al and S. Buti et al. J Clin Oncol. 2017 Jun 1;35(16):1859–1860.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2017
Volume
35
Issue
16
Start / End Page
1859 / 1860
Location
United States
Related Subject Headings
- Sunitinib
- Pyridines
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- Anilides
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences